Trending Core BUSINESS News: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group


Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group


If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.

via FOX BUSINESS NEWS Markets
https://ift.tt/3gnTgsg

Post a Comment

0 Comments